AmCham EU

AmCham EU confirms Chair of Policy Group and Member of the Board of Directors

29 Oct 2025

All committees

AmCham EU is pleased to announce the results of the confirmation that took place for the Chair of the Policy Group and Member of the Board of Directors. Congratulations to Andrea Chiarello (Pfizer) for being confirmed for a second mandate. We look forward to continuing working with Andrea as he contributes his expertise and leadership to advancing AmCham EU’s policy priorities.

Shaping effective investment screening frameworks with the CELIS Institute

29 Oct 2025

All committees

Tax

On Thursday, 24 October, Andrew Hill, Senior Policy Adviser, AmCham EU represented the organisation by speaking at the Conference on Foreign Investment Screening, hosted by the CELIS Institute.The discussion focused on the evolving landscape of investment screening in Europe and ways to ensure that the Foreign Investment Screening Regulation best supports Europe’s security. It also highlighted the importance of honing investment screening towards the most risky investments, while creating optimal pathways for cooperation between agencies. Panellists also highlighted the growing need for transatlantic cooperation, the drive toward transparent screening mechanisms and the development of investment screening as a practice, and the future of investment screening in view of economic security.

Advancing EU health policy through competitiveness and innovation

28 Oct 2025

All committees

Healthcare

On Monday, 27 October, AmCham EU met with Lorena Boix-Alonso, Deputy Director-General, Directorate-General for Health and Food Safety, European Commission, for an exchange on the role of health policy in strengthening the EU’s competitiveness. The discussion focused on how to foster innovation while ensuring patient safety, as well as ways to streamline the legislative framework to improve efficiency and uphold high standards of care. AmCham EU highlighted the importance of evidence-based, future-proof regulation that supports a resilient health system and drives innovation. Continued dialogue is essential to advancing shared goals for Europe’s health agenda.